Cancer BiologybioRxivPreprint
Activated ADAM10 targeting antibody 1H5 suppresses NOTCH-driven glioma progenitors
Umberto Tosi, Greta Ghita, Nayanendu Saha…·Viviane Tabar
This study shows that the antibody 1H5 targets activated ADAM10 to suppress NOTCH-driven glioma progenitors, reducing tumor growth and improving survival in xenograft models.
DOI 10.64898/2026.10.28.762427